Related references
Note: Only part of the references are listed.Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline (vol 162, pg e207, 2022)
James D. Douketis et al.
CHEST (2023)
Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracereoral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care
Hagen B. Huttner et al.
STROKE (2022)
Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban
Alexander P. Benz et al.
THROMBOSIS AND HAEMOSTASIS (2022)
Management of DOAC in Patients Undergoing Planned Surgery or Invasive Procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper
Alessandro Squizzato et al.
THROMBOSIS AND HAEMOSTASIS (2022)
Impact of Factor Xa Inhibitor Reversal with Prothrombin Complex Concentrate in Patients with Traumatic Brain Injuries
Grace E. Cooksey et al.
NEUROCRITICAL CARE (2022)
Prospective cohort study on the use of low molecular weight heparin calibrated anti-Xa assay for measurement of direct oral Xa inhibitors in ex vivo patient samples
Ming Sheng Lim et al.
PATHOLOGY (2022)
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association
Steven M. Greenberg et al.
STROKE (2022)
Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study
Alyaa M. Ajabnoor et al.
PLOS MEDICINE (2022)
A ten-year review of the impact of the transition from warfarin to direct oral anticoagulant - Has venous thromboembolism treatment become safer?
Brandon Lui et al.
THROMBOSIS RESEARCH (2022)
Perioperative Management of Antithrombotic Therapy An American College of Chest Physicians Clinical Practice Guideline
James D. Douketis et al.
CHEST (2022)
Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran
Florian Haertig et al.
THROMBOSIS AND HAEMOSTASIS (2021)
International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing
Steve Kitchen et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)
Direct Oral Anticoagulants Plasma Levels Measurement: Clinical Usefulness from Trials and Real-World Data
Francesca Renon et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation
Guido Willekens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Jan Steffel et al.
EUROPACE (2021)
2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
Jonathan Douxfils et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Exploring the utility of a novel point-of-care whole blood thrombin generation assay following trauma: A pilot study
Michael J. Ferrara et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban
Florian Hartig et al.
NEUROLOGICAL RESEARCH AND PRACTICE (2021)
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases
Pawel Kermer et al.
INTERNATIONAL JOURNAL OF STROKE (2020)
Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure
Joseph R. Shaw et al.
BLOOD ADVANCES (2020)
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants A Report of the American College of Cardiology Solution Set Oversight Committee
Gordon F. Tomaselli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system
Nicholas Jakowenko et al.
THROMBOSIS RESEARCH (2020)
Detecting Anti-IIa and Anti-Xa Direct Oral Anticoagulant (DOAC) Agents in Urine using a DOAC Dipstick
Job Harenberg et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Direct Oral Anticoagulant Plasma Levels for the Management of Acute Ischemic Stroke
Armin Marsch et al.
CEREBROVASCULAR DISEASES (2019)
Treatment of bleeding complications in patients on anticoagulant therapy
Siavash Piran et al.
BLOOD (2019)
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum
Adam Cuker et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers
Ramin Artang et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
European Stroke Organisation Guideline on Reversal of Oral Anticoagulants in Acute Intracerebral Haemorrhage
Hanne Christensen et al.
EUROPEAN STROKE JOURNAL (2019)
The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition
Donat R. Spahn et al.
CRITICAL CARE (2019)
Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation A Systematic Review and Meta-Analysis
Marco Proietti et al.
STROKE (2018)
Reversal agents for non-vitamin K antagonist oral anticoagulants
Jerrold H. Levy et al.
NATURE REVIEWS CARDIOLOGY (2018)
Clinical outcome of patients with a vitamin K antagonist-associated bleeding treated with prothrombin complex concentrate
Marjolein P. A. Brekelmans et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
POST-NOAC: Portuguese observational study of intracranial hemorrhage on non-vitamin K antagonist oral anticoagulants
Claudia Marques-Matos et al.
INTERNATIONAL JOURNAL OF STROKE (2017)
Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke
David J. Seiffge et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Coagulation Testing in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants
Jan C. Purrucker et al.
STROKE (2017)
Door-to-Imaging Time for Acute Stroke Patients Is Adversely Affected by Emergency Department Crowding
Martin A. Reznek et al.
STROKE (2017)
Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations
I. H. Jaffer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
Charles V. Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants Limitations and Solutions
Matthias Ebner et al.
STROKE (2017)
Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents
Thorsten Steiner et al.
STROKE (2017)
Management of Severe Bleeding in Patients Treated with Direct Oral Anticoagulants An Observational Registry Analysis
Pierre Albaladejo et al.
ANESTHESIOLOGY (2017)
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy
Renato D. Lopes et al.
BLOOD (2017)
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants
Matthias Ebner et al.
CRITICAL CARE (2017)
When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
J. H. Levy et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics
Sophie Testa et al.
THROMBOSIS RESEARCH (2016)
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
Torben Bjerregaard Larsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
Torben Bjerregaard Larsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants
Jan C. Purrucker et al.
JAMA NEUROLOGY (2016)
National Trends in Ambulatory Oral Anticoagulant Use
Geoffrey D. Barnes et al.
AMERICAN JOURNAL OF MEDICINE (2015)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Idarucizumab for Dabigatran Reversal
Charles V. Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Intracranial haemorrhage in patients treated with direct oral anticoagulants
Christopher Beynon et al.
THROMBOSIS RESEARCH (2015)
New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management
H. Tran et al.
INTERNAL MEDICINE JOURNAL (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis
L. C. Lopes et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
An update of consensus guidelines for warfarin reversal
Huyen A. Tran et al.
MEDICAL JOURNAL OF AUSTRALIA (2013)
Oral Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Walter Ageno et al.
CHEST (2012)
Share Paper
